This ridculous patent in Europe is out of control!
Myriad Genetics of Salt Lake City won a European patent on 1 July covering a specific mutation in the BRCA2 gene, which increases the risk of breast cancer. The mutation is found in 1 in 100 women of Ashkenazi Jewish descent. The ruling means that doctors offering tests for BRCA2 mutations are now legally obliged to ask women if they are Ashkenazi Jews. If they say they are, doctors must pay a licence fee to Myriad. No fee is due if a patient says she does not know.
This is great lets get a patent on the Aids strain for Hispanice or any other ethnic group. If they say they are that ethnic group you could get a licence fee? I'm rich! (well not yet but I'm working on it).
Myriad Genetics of Salt Lake City won a European patent on 1 July covering a specific mutation in the BRCA2 gene, which increases the risk of breast cancer. The mutation is found in 1 in 100 women of Ashkenazi Jewish descent. The ruling means that doctors offering tests for BRCA2 mutations are now legally obliged to ask women if they are Ashkenazi Jews. If they say they are, doctors must pay a licence fee to Myriad. No fee is due if a patient says she does not know.
This is great lets get a patent on the Aids strain for Hispanice or any other ethnic group. If they say they are that ethnic group you could get a licence fee? I'm rich! (well not yet but I'm working on it).
No comments:
Post a Comment